BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8587841)

  • 1. [31P-MR spectroscopy of bone and soft tissue lesions].
    Kitagawa A; Saeki M; Imamura K; Ohashi K; Ishikawa T; Nakajima H; Takagi M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Dec; 55(15):1017-24. PubMed ID: 8587841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes of 3-tesla 31P-MR spectroscopy of bone and soft tissue tumors].
    Qi ZH; Li CF; Ma XX; Li ZF; Zhang K; Yu DX
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):442-6. PubMed ID: 19950555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
    Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
    Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone and soft-tissue lesions: diagnosis with combined H-1 MR imaging and P-31 MR spectroscopy.
    Negendank WG; Crowley MG; Ryan JR; Keller NA; Evelhoch JL
    Radiology; 1989 Oct; 173(1):181-8. PubMed ID: 2675183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo 31P NMR spectroscopy of human musculoskeletal tumors as a measure of response to chemotherapy.
    Möller HE; Vermathen P; Rummeny E; Wörtler K; Wuisman P; Rössner A; Wörmann B; Ritter J; Peters PE
    NMR Biomed; 1996 Dec; 9(8):347-58. PubMed ID: 9176889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of bone and soft-tissue tumors with in vivo 1H MR spectroscopy: initial results.
    Wang CK; Li CW; Hsieh TJ; Chien SH; Liu GC; Tsai KB
    Radiology; 2004 Aug; 232(2):599-605. PubMed ID: 15286325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of MRS in the differentiation of benign and malignant soft tissue and bone tumors.
    Doganay S; Altinok T; Alkan A; Kahraman B; Karakas HM
    Eur J Radiol; 2011 Aug; 79(2):e33-7. PubMed ID: 21376496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear magnetic resonance studies on human bone and soft tissue tumors.
    Mizuta H; Yamasaki M
    Nihon Seikeigeka Gakkai Zasshi; 1984 Jan; 58(1):97-106. PubMed ID: 6747405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR spectroscopy of musculoskeletal soft-tissue tumors.
    Negendank WG
    Magn Reson Imaging Clin N Am; 1995 Nov; 3(4):713-25. PubMed ID: 8564691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary study of proton magnetic resonance spectroscopy in bone and soft tissue tumors: an unassigned signal at 2.0-2.1 ppm may be a possible indicator of malignant neuroectodermal tumor.
    Oya N; Aoki J; Shinozaki T; Watanabe H; Takagishi K; Endo K
    Radiat Med; 2000; 18(3):193-8. PubMed ID: 10972550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton magnetic resonance spectroscopy of musculoskeletal lesions at 3 T with metabolite quantification.
    Lee CW; Lee JH; Kim DH; Min HS; Park BK; Cho HS; Kang HG; Suh JS; Ehara S
    Clin Imaging; 2010; 34(1):47-52. PubMed ID: 20122519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo 1H MRS for musculoskeletal lesion characterization: which factors affect diagnostic accuracy?
    Wang CK; Li CW; Hsieh TJ; Lin CJ; Chien SH; Tsai KB; Chang KC; Tsai HM
    NMR Biomed; 2012 Feb; 25(2):359-68. PubMed ID: 21793078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [MR imaging of primary bone and soft tissue tumors].
    Uchida M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Jun; 50(6):637-48. PubMed ID: 2235314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Application value of 3T 1H-magnetic resonance spectroscopy in diagnosing tumors of bone and soft tissue].
    Qi ZH; Li CF; Ma XX; Li ZF; Zhang K; Yu DX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Oct; 33(5):504-10. PubMed ID: 22338133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A comparative study between magnetic resonance imaging and histological findings of bone and soft tissue tumors].
    Itoh K
    Nihon Seikeigeka Gakkai Zasshi; 1995 Oct; 69(10):899-914. PubMed ID: 8551093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
    Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
    J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical applicability of human in vivo localized phosphorus-31 magnetic resonance spectroscopy of bone and soft tissue tumors.
    Hoekstra HJ; Boeve WJ; Kamman RL; Mooyaart EL
    Ann Surg Oncol; 1994 Nov; 1(6):504-11. PubMed ID: 7850556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy and limitations of fine-needle aspiration cytology of bone and soft tissue lesions: a review of 1114 cases with cytological-histological correlation.
    Khalbuss WE; Teot LA; Monaco SE
    Cancer Cytopathol; 2010 Feb; 118(1):24-32. PubMed ID: 20091838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [MR imaging of bone and soft tissue tumors].
    Nishimura H; Koganemaru M; Uchida M; Ohtake H; Nakashima M
    Rinsho Hoshasen; 1990 Jan; 35(1):57-68. PubMed ID: 2313923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances.
    Menon DK; Sargentoni J; Taylor-Robinson SD; Bell JD; Cox IJ; Bryant DJ; Coutts GA; Rolles K; Burroughs AK; Morgan MY
    Hepatology; 1995 Feb; 21(2):417-27. PubMed ID: 7843715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.